Curative Biotechnology, Inc. CUBT

Company Overview

Curative Biotechnology, Inc. (CUBT) is a publicly traded biotechnology and medical products company that has historically focused on the development, manufacturing, and commercialization of advanced wound care and antimicrobial solutions. The company operates within the biotechnology, medical devices, and healthcare products industries, with an emphasis on technologies intended to improve infection control and healing outcomes in clinical and consumer settings.

The company’s primary business activities have centered on wound care products, including antimicrobial dressings and topical solutions designed for chronic and acute wound management. Public disclosures indicate that Curative Biotechnology has undergone multiple strategic and operational shifts over time, including changes in product focus and commercialization strategy. Data inconclusive based on available public sources regarding the company’s current revenue scale and active product portfolio.